Reconova closes Series B at CNY400M post-money
Reconova completed its Series B financing at an issuer-disclosed CNY400M post-money valuation. The filing lists CNY50000000 of primary consideration among the disclosed retained investors.
Evidence notes
- Issuer prospectus states pre-money valuation of CNY350000000 and post-money valuation of CNY400000000.
- Primary consideration treatment: CNY50M aggregate primary subscriptions retained in the filing table.
- Investors: Wuxi ST Zhihang (SWLVC), Shihezi Shangshi Growth (SSG)